Summary
The effect of the antiserum to Nerve Growth Factor (NGF) on the regrowth of adrenergic axons following 6-hydroxydopamine-(6-OH-DA)induced axotomy was investigated in the mouse using fluorescence histochemistry and determinations of endogenous NA. A single subcutaneous injection of 0.1 ml/g of anti-NGF serum, given one day after the 6-OH-DA-injection (60 mg/kg), caused a pronounced inhibition of the regeneration of the adrenergic axons in all peripheral tissues investigated (iris, salivary glands, heart, intestine, spleen and pancreas). The ganglionic cell bodies in the superior cervical ganglion underwent a marked atrophy, as observed 5 days and 3 weeks after the 6-OH-DA treatment, but they had regained normal appearance after 2 months. Furthermore, the fluorescence histochemistry revealed an antiserum-induced reduction of the NA content in all parts of the regenerating neurons, except for the most distal portions of the surviving axon stumps. At 5 days and 3 weeks after the 6-OH-DA-treatment the sprouting and regrowth of the adrenergic axons were much reduced in the anti-NGF serum-treated animals. When compared with those of the corresponding controls, the NA levels in the anti-NGF serum-treated specimens were only 20–40% at 3 weeks. The anti-NGF serum-induced inhibition was temporary, and between 3 weeks and 2 months after treatment the regeneration in the antiserum-treated animals started to catch up with the controls. The results indicate that endogenous NGF or NGF-like substances may play a role in the process of regeneration of lesioned sympathetic neurons in the adult animal. They also suggest that mature sympathetic neurons during regeneration resume the high sensitivity to, and dependence on, NGF, which otherwise are characteristic of sympathetic neurons during their ontogenetic growth and development.
Similar content being viewed by others
References
Angeletti, R. H., Angeletti, P. U., Levi-Montalcini, R.: Selective accumulation of [125I] labelled nerve growth factor in sympathetic ganglia. Brain Res. 46, 421–425 (1972)
Angeletti, P. U., Gandini-Attardi, P., Toschi, G., Salvi, M. L., Levi-Montalcini, R.: Metabolic aspects of the effect of nerve growth factor on sympathetic and sensory ganglia:protein and ribonucleic acid synthesis. Biochim. biophys. Acta (Amst.) 95, 111–120 (1965)
Angeletti, P. U., Levi-Montalcini, R., Caramia, F.: Analysis of the effects of the antiserum tothe nerve growth factor in adult mice. Brain Res. 27, 343–355 (1971)
Bertler, Å., Carlsson, A., Rosengren, E., Waldeck, B.: A method for the fluorimetric determinations of adrenaline, noradrenaline, and dopamine in tissues. Kungl. Fysiogr. Sällsk.Lund Förh. 28, 121–123 (1958)
Bjerre, B., Björklund, A., Mobley, W.: A stimulatory effect by Nerve Growth Factor on theregrowth of adrenergic nerve fibers in the mouse peripheral tissues after chemical sympathectomy with 6-hydroxydopamine. Z. Zellforsch. 146, 15–43 (1973a)
Bjerre, B., Björklund, A., Stenevi, U.: Stimulation of growth of new axonal sprouts fromlesioned monoamine neurones in adult rat brain by nerve growth factor. Brain Res. 60, 161–176 (1973b)
Bjerre, B., Björklund, A., Stenevi, U.: Inhibition of the regenerative growth of central nor-adrenergic neurons by intracerebrally administered anti-NGF serum. Brain Res. (in press), (1974)
Björklund, A., Falck, B., Owman, Ch.: Fluorescence microscopic and microspectrofluorometrictechniques for the cellular localization and characterization of biogenic amines. In: J. E. Rall and I. J., Kopin (eds.), Methods in investigative and diagnostic endocrinology, vol. 1,The thyroid and biogenic amines, p. 318–368. Amsterdam-London: North Holland Publ.Comp. 1972
Brattgård, S.-O., Edström, J. E., Hydén, H.: The chemical changes in regenerating neurons. J. Neurochem. 1, 316–325 (1957)
Burnham, P., Varon, S.: In vitro uptake of active nerve growth factor by dorsal root ganglia of embryonic chick. Neurobiology 3, 232–245 (1973)
Cobb, J.L.S., Bennett, T.: An electron microscopic examination of the short term effects of 6-hydroxydopamine on the peripheral adrenergic nervous system. In: T., Malmfors and H. Thoenen (eds.), 6-Hydroxydopamine and catecholamine neurons, p. 33–45. Amsterdam-London: North-Holland Publ. Comp. 1971
Cohen, S.: Purification of a nerve-growth promoting protein from the mouse salivary glandsand its neuro-cytotoxic antiserum. Proc. nat. Acad. Sci. (Wash.) 46, 302–311 (1960)
De Champlain, J.: Degeneration and regrowth of adrenergic nerve fibres in the rat peripheral tissues after 6-hydroxydopamine. Canad. J. Physiol. Pharmacol. 49, 345–355 (1971)
De Champlain, J., Malmfors, T., Olson, L., Sachs, Ch.: Ontogenesis of peripheral adrenergic neurons in the rat: Preand postnatal observations. Acta physiol. scand. 80, 276–288 (1970)
Edwards, D. C., Fenton, E. L., Hendry, I. A.: Quantitative aspects of the effects in mice of nerve growth factor and its antiserum. In: E. Zaimis and J. Knight (eds.), Nerve growthfactor and its antiserum, p. 237–252. London: The Athlone Press of the University of London 1972
Fenton, E. L.: Tissue culture assay of nerve growth factor and of the specific antiserum. Exp. Cell Res. 59, 383–392 (1970)
Guth, L.: Regeneration in the mammalian peripheral nervous system. Physiol. Rev. 36, 441–478 (1956)
Haeusler, G., Haefely, W., Thoenen, H.: Chemical sympathectomy of the cat with 6-hydroxydopamine. J. Pharmacol. exp. Ther. 170, 50–61 (1969)
Häggendahl, J.: An improved method for fluorimetric determination of small amounts of adrenaline and noradrenaline in plasma and tissues. Acta physiol. scand. 59, 242–254 (1963)
Hamberger, B., Levi-Montalcini, R., Norberg, K.-A., Sjöqvist, F.: Monoamines in immunosympathectomized rats. Int. Neuropharmacol. 4, 91–95 (1965)
Hendry, I. A.: Developmental changes in tissue and plasma concentrations of the biologically active species of nerve growth factor in the mouse, by using a two-site radioimmunoassay. Biochem. J. 128, 1265–1272 (1972)
Hendry, I. A., Addison, G. M., Iversen, L. L.: Radioimmunoassay of nerve growth factor from mouse salivary gland. In: E. Zaimis and J. Knight (eds.), Nerve growth factor and its antiserum, p. 262–270. London: The Athlone Press of the University of London 1972
Iversen, L. L., Glowinski, J., Axelrod, J.: The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. J. Pharmacol. exp. Ther. 151, 273–284 (1966)
Johnson, D. G., Gordon, P., Kopin, I. J.: A sensitive radioimmunoassay for 7S nerve growth factor antigens in serum and tissues. J. Neurochem. 18, 2355–2362 (1971)
Jonsson, G., Sachs, Ch.: Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons. Europ. J. Pharmacol. 9, 141–155 (1970)
Kirpekar, S. M., Wakade, A. R., Prat, J. C.: Regeneration of sympathetic nerves to the vas deferens and spleen of the cat. J. Pharmacol. exp. Ther. 175, 197–205 (1970)
Klingman, G. I.: Catecholamine levels and dopa-decarboxylase activity in peripheral organs and adrenergic tissues in the rat after immunosympathectomy. J. Pharmacol. exp. Ther. 148, 14–21 (1965)
Kumar, S., Steward, J. K.: A possible site of action of the nerve growth factor. Exp. Cell Res. 63, 200–201 (1970)
Larrabee, M. G.: Metabolism during development in sympathetic ganglia of chickens: Effects of age, nerve growth factor and metabolic inhibitors. In: E. Zaimis and J. Knight (eds.), Nerve growth factor and its antiserum, p. 71–88. London: The Athlone press of the University of London 1972
Levi-Montalcini, R.: The morphological effects of immunosympathectomy. In: G. Steiner and E. Schönbaum (eds.), Immunosympathectomy, p. 55–78. Amsterdam-London: North-Holland Publ. Comp. 1972
Levi-Montalcini, R., Angeletti, P. U.: Noradrenaline and monoamineoxidase content in immunosympathectomized animals. Int. J. Neuropharmacol. 1, 161–164 (1962)
Levi-Montalcini, R., Angeletti, P. U.: Immunosympathectomy. Pharmacol. Rev. 18, 619–628 (1966)
Levi-Montalcini, R., Angeletti, P. U.: Nerve growth factor. Physiol. Rev. 48, 435–569 (1968)
Levi-Montalcini, R., Angeletti, R. H., Angeletti, P. U.: The nerve growth factor. In: G. H. Bourne (ed.): The structure and function of nervous tissue, vol. V, p. 1–38. New York-London: Academic Press 1972
Levi-Montalcini, R., Booker, B.: Destruction of the sympathetic ganglia in mammals by an antiserum to the nerve-growth protein. Proc. nat. Acad. Sci. (Wash.) 46, 384–391 (1960)
Liebermann, A. R: The axon reaction: A review of the principal features of perikaryal responses to axon injury. In: C. C. Pfeiffer and J. R. Smythies (eds.), Int. Rev. Neurobiol. 14, 49–124 (1971)
Malmfors, T.: The effects of 6-hydroxydopamine on the adrenergic nerves as revealed by the fluorescence histochemical method. In: T. Malmfors and H. Thoenen (eds.), 6-hydroxydopamine and catecholamine neurons, p. 47–58. Amsterdam-London: North-Holland Publ. Comp. 1971
Malmfors, T., Sachs, Ch.: Degeneration of adrenergic nerves produced by 6-hydroxydopamine. Europ. J. Pharmacol. 3, 89–92 (1968)
Matthews, M. R., Raismann, G.: A light and electron microscopic study of the cellular response to axonal injury in the superior cervical ganglion of the rat. Proc. roy. Soc. B. 181, 43–79 (1972)
Mirkin, B. L.: Ontogenesis of the adrenergic neuron. In: G. Steiner and E. Schönbaum (eds.), Immunosympathectomy, p. 79–89. Amsterdam-London: North-Holland Publ. Comp. 1972
Olson, L.: Intact and regenerating sympathetic noradrenaline axons in the rat sciatic nerve. Histochemie 17, 349–367 (1969)
Olson, L., Malmfors, T.: Growth characteristics of adrenergic nerves in the adult rat. Acta physiol. scand., Suppl. 348, 1–112 (1970)
Owman, Ch., Sjöberg, N. O., Swedin, G.: Histochemical and chemical studies on pre and postnatal development of the different systems of “short” and “long” adrenergic neurons in peripheral organs of the rat. Z. Zellforsch. 116, 319–341 (1971)
Owman, Ch., Sjöstrand, N. O.: Short adrenergic neurons and catecholamine-containing cells in vas deferens and accessory male genital glands of different mammals. Z. Zellforsch. 66, 300–320 (1965)
Roisen, F. J., Murphy, R. A., Braden, W. G.: Dibuturyl cyclic adenosine monophosphate stimulation of colcemid-inhibited axonal elongation. Science 177, 809–811 (1972a)
Roisen, F. J., Murphy, R. A., Pichichero, M. E., Braden, W. G.: Cyclic adenosine monophosphate stimulation of axonal elongation. Science 175, 73–74 (1972b)
Sabatini, M. T., Pellegrino de Iraldi, A., De Robertis, E.: Early effects of antiserum against the nerve growth factor on fine structure of sympathetic neurons. Exp. Neurol. 12, 370–383 (1965)
Sjöstrand, N. O.: The adrenergic innervation of the vas deferens and the accessory male genital glands. Acta physiol. scand. 65, Suppl. 257 (1965)
Smith, A. P., Varon, S., Shooter, E. M.: Multiple forms of the nerve growth factor protein and its subunits. Biochemistry 7, 3259–3268 (1968)
Stenevi, U., Bjerre, B., Björklund, A., Mobley, W.: Effects of localized intracerebral injections of Nerve Growth Factor on the regenerative growth of central noradrenergic neurones. Brain Res. 69, 217–234 (1974)
Thoenen, H.: Comparison between the effect of neuronal activity and nerve growth factor on the enzymes involved in the synthesis of norepinephrine. Pharmacol. Rev. 24, 255–267 (1972)
Thoenen, H., Angeletti, P. U., Levi-Montalcini, R., Kettler, R.: Selective induction by nerve growth factor of tyrosine hydroxylase and dopamine-β-hydroxylase in the rat superior cervical ganglia. Proc. nat. Acad. Sci. (Wash.) 68, 1598–1602 (1971)
Thoenen, H., Hendry, I. A., Stöckel, K., Paravicini, V., Oesch, F.: Regulation of enzyme synthesis by neuronal activity and by nerve growth factor. In: K. Fuxe, L. Olson, Y. Zottermann (eds.), Dynamics of degeneration and growth in neurons, Oxford: Pergamon Press (to be published, 1974)
Thoenen, H., Tranzer, J. P.: Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 261, 271–288 (1968)
Tranzer, J. P., Richards, J. C.: Fine structural aspects of the effect of 6-hydroxydopamine on peripheral adrenergic neurons. In: T. Malmfors and H. Thoenen (eds.), 6-Hydroxydopamine and catecholamine neurons, p. 15–31. Amsterdam-London: North-Holland Publ. Comp. 1971
Tranzer, J. P., Thoenen, H.: Ultramorphologische Veränderung der sympathischen Nervenendigungen der Katze nach Vorbehandlung mit 5-und 6-Hydroxy-Dopamin. NaunynSchmiedebergs Arch. Pharmak. exp. Path. 257, 343–344 (1967)
Tranzer, J. P., Thoenen, H.: An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia (Basel) 24, 155–156 (1968)
Varon, S., Nomura, J., Shooter, E. M.: The isolation of the mouse nerve growth factor protein in a high molecular weight form. Biochemistry (N.Y.) 6, 2202–2209 (1967a)
Varon, S., Nomura, J., Shooter, E. M.: Subunit structure of a high-molecular-weight form of the nerve growth factor from mouse submaxillary gland. Proc. nat. Acad. Sci. (Wash.) 57, 1782–1789 (1967b)
Vogt, M.: Sources of noradrenaline in the “immunosympathectomized” rat. Nature (Lond.) 204, 1315–1316 (1964)
Winick, M., Greenberg, R. E.: Appearance and localization of a nerve growth-promoting protein during development. Pediatrics 35, 221–228 (1965)
Zaimis, E., Berk, L., Callingham, B. A.: Morphological, biochemical and functional changes in the sympathetic nervous system of rats treated with nerve growth factor-antiserum. Nature (Lond.) 206, 1220–1222 (1965)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bjerre, B., Björklund, A. & Edwards, D.C. Axonal regeneration of peripheral adrenergic neurons: Effects of antiserum to nerve growth factor in mouse. Cell Tissue Res. 148, 441–476 (1974). https://doi.org/10.1007/BF00221931
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00221931